FUSARO, MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.012
NA - Nord America 864
EU - Europa 551
SA - Sud America 345
AF - Africa 25
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.800
Nazione #
SG - Singapore 880
US - Stati Uniti d'America 815
CN - Cina 425
BR - Brasile 270
VN - Vietnam 223
HK - Hong Kong 195
IT - Italia 151
FR - Francia 113
NL - Olanda 113
JP - Giappone 78
KR - Corea 69
FI - Finlandia 58
IN - India 32
DE - Germania 31
BD - Bangladesh 25
AR - Argentina 22
CA - Canada 22
EC - Ecuador 20
GB - Regno Unito 20
MX - Messico 12
ID - Indonesia 10
IL - Israele 10
PL - Polonia 9
UY - Uruguay 9
VE - Venezuela 9
TR - Turchia 8
UA - Ucraina 7
DZ - Algeria 6
IQ - Iraq 6
CL - Cile 5
CO - Colombia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AM - Armenia 4
CH - Svizzera 4
CR - Costa Rica 4
ES - Italia 4
GR - Grecia 4
KE - Kenya 4
RU - Federazione Russa 4
ZA - Sudafrica 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
JO - Giordania 3
LK - Sri Lanka 3
LV - Lettonia 3
NP - Nepal 3
SE - Svezia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
HN - Honduras 2
IE - Irlanda 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MV - Maldive 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.799
Città #
Singapore 531
Santa Clara 267
Hong Kong 192
Hefei 168
San Jose 103
Beijing 102
Lauterbourg 98
Ho Chi Minh City 74
Seoul 67
Tokyo 67
Hanoi 60
Ashburn 55
Council Bluffs 38
Los Angeles 35
Dallas 32
Lappeenranta 30
Helsinki 26
New York 22
São Paulo 20
Haiphong 14
Orem 13
Rome 13
Buffalo 12
Guayaquil 9
Minamishinagawa 9
Montevideo 9
Warsaw 9
Belo Horizonte 8
Chennai 8
Munich 8
Rio de Janeiro 8
Bengaluru 7
Can Tho 7
Florence 7
Milan 7
Nuremberg 7
Phoenix 7
Toronto 7
Amsterdam 6
Brasília 6
Quito 6
Thái Bình 6
Atlanta 5
Fortaleza 5
Frankfurt am Main 5
Tashkent 5
Athens 4
Bắc Giang 4
Cascina 4
Da Nang 4
Elk Grove Village 4
London 4
Nairobi 4
Naples 4
San José 4
Santiago 4
Volta Redonda 4
Amman 3
Baghdad 3
Bari 3
Brescia 3
Brooklyn 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Carapicuíba 3
Catania 3
Chicago 3
Colombo 3
Contagem 3
Falkenstein 3
Gustavo Adolfo Madero 3
Hangzhou 3
Hyderabad 3
Madrid 3
Manaus 3
Miami 3
Montreal 3
New Delhi 3
Ninh Bình 3
Paris 3
Porto Alegre 3
Ribeirão Preto 3
Riga 3
San Francisco 3
Stockholm 3
São Gonçalo 3
São José dos Campos 3
Tbilisi 3
Teófilo Otoni 3
Thái Nguyên 3
Turin 3
Yerevan 3
Zurich 3
Algiers 2
Batna City 2
Biên Hòa 2
Bogotá 2
Bragança Paulista 2
Buenos Aires 2
Totale 2.367
Nome #
Bone Mineral Density Predicts Fractures in Chronic Kidney Disease 96
Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives 89
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method 89
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis 72
Vitamin K2 is a key regulator of clinically relevant molecular processes 69
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease 66
[Biomarkers and Bone Turnover Markers in Chronic Kidney Disease - Mineral and Bone Disorders (CKD-MBD): Recent Advances] 59
Vitamin K in CKD Bone Disorders 58
Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines 57
The Role of Vitamin K in CKD-MBD 57
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients 55
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options 52
Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study 52
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? 51
Romosozumab Use and Cardiovascular Events 51
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve 50
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism 50
Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population 47
SEVELAMER USE IS ASSOCIATED WITH DECREASED VITAMIN K LEVELS IN HEMODIALYSIS PATIENTS: RESULTS FROM VITAMIN K ITALIAN (VIKI) STUDY. 47
Simple Statistical Measures for Assessing the Accuracy of a Diagnostic Test in Clinical Medicine 47
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease 47
A Novel Quantitative Computer-Assisted Score Can Improve Repeatability in the Estimate of Vascular Calcifications at the Abdominal Aorta 46
The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study 45
Sex-related differences in vitamin D testing in the Veneto Region, Italy: a retrospective analysis from 2005 to 2016 45
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 44
New Insight into the Role of Vitamin D in the Stroke Risk: A Meta-Analysis of Stratified Data by 25(OH)D Levels 43
Ten tips on how to assess bone health in patients with chronic kidney disease 43
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study 41
Vitamin D assay and supplementation: still debatable issues 41
Vitamin K plasma levels determination in human health 40
Comprehensive Associations between Acidosis and the Skeleton in Patients with Kidney Disease 40
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes 40
Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon? 39
Phosphate and bone fracture risk in chronic kidney disease patients 39
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices 39
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 39
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 38
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action 38
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes 37
Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs 36
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter 36
Changes in Bone Quality after Treatment with Etelcalcetide 36
Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet 35
Clinical relevance and future perspective of fractures in patients with chronic kidney disease 35
Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study 35
Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake 35
Evaluating benefit from vitamin D supplementation: defining the area for treatment 35
Vitamin K and kidney transplantation 34
Vitamin K and osteoporosis 34
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor 33
Vitamin K and bone 32
Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients 32
Fragility fracture in the Chronic Kidney Disease (CKD) 32
A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update 32
Percorso diagnostico-terapeutico per il paziente con calcolosi renale: update 2020 31
HO-1 Attenuates Hypertension-Induced Inflammation/Oxidative Stress: Support From Bartter's/Gitelman's Patients 31
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients 31
High-resolution peripheral quantitative computed tomography: research or clinical practice? 30
CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DISEASE 30
Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship 30
Vitamin K effects in human health: new insights beyond bone and cardiovascular health 30
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data 29
SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: Implications for hypertension 29
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs 29
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 29
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data 28
Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation 28
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy 28
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 27
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients 27
A new CHA2DS2VASC score integrated with eGFR, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease. 27
Effect of olmesartan on oxidative stress in hypertensive patients. Mechanistic support to clinical trials derived evidence 27
Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report 26
Fractures in chronic kidney disease: neglected, common, and associated with sickness and death 26
Vitamin K effects in human health: new insights beyond bone and cardiovascular health (vol 33, pg 239, 2020) 26
Adverse effects of proton pump inhibitors in chronic kidney disease 26
CIGARETTE SMOKING IS ASSOCIATED WITH DECREASED BGP LEVELS IN HEMODIALYSIS PATIENTS 26
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3 25
Low vitamin K1 intake in haemodialysis patients 25
WARFARIN USE IS ASSOCIATED WITH HIGHER PREVALENCE VERTEBRAL FRACTURES, VASCULAR CALCIFICATIONS AND INCREASED MORTALITY IN CHRONIC KIDNEY DISEASE 25
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective 25
The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures 25
High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications 24
VITAMIN K DEPENDENT PROTEINS AFTER KIDNEY TRANSPLANTATION: RESULTS FROM PROSPECTIVE STUDY. 24
EVALUATION OF VITAMIN D STATUS DURING KIDNEY TRANSPLANTATION: FACTORS RELATED AND EFFECT OF THE TREATMENT 24
Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid covid-19 patients: A hypothesis-generating study 24
Utility of Cardiac Biomarkers in the Setting of Kidney Disease 24
Vitamin K and bone metabolism in the elderly with normal and reduced kidney function 23
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1–3 23
Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder 23
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 23
Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease 23
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 22
How and when to assess bone mineral density and bone quality in chronic kidney disease patients 22
The Role of Vitamin K in Vascular Calcification 22
Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis 22
Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies 22
DECREASED OSTEOCALCIN LEVELS AND INCREASED MORTALITY IN HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS 21
SERUM LEVELS OF FAT-SOLUBLE VITAMIN D AND VITAMIN K IN SEVELAMER TREATED END STAGE RENAL DISEASE PATIENTS 21
HIGHER BMI IS ASSOCIATED WITH DECREASED VITAMIN K2 LEVELS IN HEMODIALYSIS PATIENTS 21
Totale 3.694
Categoria #
all - tutte 14.913
article - articoli 13.311
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 203
Totale 28.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 0 3 5 1
2024/20251.671 2 6 98 85 443 45 76 74 47 132 376 287
2025/20262.317 123 215 248 347 402 52 347 138 174 174 97 0
Totale 3.997